-
1
-
-
84882464229
-
FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Withdraws the Product
-
30 September. on 30 September 2004
-
U.S. Food and Drug Administration. FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Withdraws the Product. FDA News. 30 September 2004. Accessed at www.fda.gov/bbs/topics/news/2004/NEW01122.html on 30 September 2004.
-
(2004)
FDA News
-
-
-
2
-
-
4944229572
-
Merck withdraws arthritis drug worldwide
-
Singh D. Merck withdraws arthritis drug worldwide. BMJ. 2004;329:816.
-
(2004)
BMJ
, vol.329
, pp. 816
-
-
Singh, D.1
-
3
-
-
6044267892
-
Failing the public health - Rofecoxib, Merck, and the FDA
-
Topol EJ. Failing the public health - rofecoxib, Merck, and the FDA. N Engl J Med. 2004;351:1707-9.
-
(2004)
N Engl J Med
, vol.351
, pp. 1707-1709
-
-
Topol, E.J.1
-
5
-
-
7044246370
-
-
Whitehouse Station, NJ: Merck & Co., Inc.; on 30 September 2004
-
Merck announces voluntary worldwide withdrawal of VIOXX®. News release. Whitehouse Station, NJ: Merck & Co., Inc.; 2004;1-3. Accessed at www.vioxx.com/rofecoxib/vioxx/consumer/index.jsp on 30 September 2004.
-
(2004)
Merck Announces Voluntary Worldwide Withdrawal of VIOXX®. News Release
, pp. 1-3
-
-
-
6
-
-
0036904515
-
Drug safety withdrawals: Who is responsible for notifying patients?
-
Wolfe SM. Drug safety withdrawals: who is responsible for notifying patients? [Editorial] Pharmacoepidemiol Drug Saf. 2002;11:641-2.
-
(2002)
Pharmacoepidemiol Drug Saf
, vol.11
, pp. 641-642
-
-
Wolfe, S.M.1
-
7
-
-
0034183399
-
Drug recalls underscore safety concerns
-
Greene HL. Drug recalls underscore safety concerns. Health News. 2000;6:4.
-
(2000)
Health News
, vol.6
, pp. 4
-
-
Greene, H.L.1
-
8
-
-
0029062698
-
Wanted: Timely receipt of drug-recall information
-
author reply 1011-2
-
Lima HA, Fisk RA. Wanted: timely receipt of drug-recall information [Letter]. Am J Health Syst Pharm. 1995;52:1010-1; author reply 1011-2.
-
(1995)
Am J Health Syst Pharm
, vol.52
, pp. 1010-1011
-
-
Lima, H.A.1
Fisk, R.A.2
-
9
-
-
0037103301
-
Contacting patients of a Pakistani hospital about a drug recall
-
Zaidi ST, Sheikh AL, Raza SS. Contacting patients of a Pakistani hospital about a drug recall [Letter]. Am J Health Syst Pharm. 2002;59:1569.
-
(2002)
Am J Health Syst Pharm
, vol.59
, pp. 1569
-
-
Zaidi, S.T.1
Sheikh, A.L.2
Raza, S.S.3
-
10
-
-
0030953419
-
Lessons from the influenza vaccine recall of 1996-1997
-
Poland GA. Lessons from the influenza vaccine recall of 1996-1997. JAMA. 1997;278:1022-3.
-
(1997)
JAMA
, vol.278
, pp. 1022-1023
-
-
Poland, G.A.1
-
11
-
-
0036905577
-
High rates of adverse effects and patient unawareness of withdrawn lipid-lowering drug combination in a public hospital clinic
-
Schiff GD, Keehr LM, Sai TT, Bult J. High rates of adverse effects and patient unawareness of withdrawn lipid-lowering drug combination in a public hospital clinic. Pharmacoepidemiol Drug Saf. 2002;11:643-5.
-
(2002)
Pharmacoepidemiol Drug Saf
, vol.11
, pp. 643-645
-
-
Schiff, G.D.1
Keehr, L.M.2
Sai, T.T.3
Bult, J.4
-
12
-
-
1542613779
-
Cerebral infarcts in a pediatric patient secondary to phenylpropanolamine, a recalled medication
-
Delorio NM. Cerebral infarcts in a pediatric patient secondary to phenylpropanolamine, a recalled medication. J Emerg Med. 2004;26:305-7.
-
(2004)
J Emerg Med
, vol.26
, pp. 305-307
-
-
Delorio, N.M.1
-
13
-
-
0035802056
-
Physician liability and drug recalls
-
Johnson LJ. Physician liability and drug recalls. Med Econ. 2001;78:118.
-
(2001)
Med Econ
, vol.78
, pp. 118
-
-
Johnson, L.J.1
-
14
-
-
0029246686
-
Competence assessment; requirements of a drug recall system; dealing with ethical issues
-
Rich DS. Competence assessment; requirements of a drug recall system; dealing with ethical issues. Hosp Pharm. 1995;30:165-71.
-
(1995)
Hosp Pharm
, vol.30
, pp. 165-171
-
-
Rich, D.S.1
-
15
-
-
13244272558
-
Zix Corporation's e-prescribing application helps physicians with vioxx recall
-
4 October. on 11 October 2004
-
Zix Corporation's e-prescribing application helps physicians with vioxx recall. Forbes Business Wire. 4 October 2004. Accessed at www.forbes.com/ businesswire/feeds/businesswire/2004/10/04/businesswire20041004005144r1.html on 11 October 2004.
-
(2004)
Forbes Business Wire
-
-
-
18
-
-
0037928503
-
Managing technology in a complex healthcare delivery system
-
Harris CM, Burns J, Gregorich T, Kall G, Piar PM, Miller HD, et al. Managing technology in a complex healthcare delivery system. J Healthc Inf Manag. 2003;17:37-41.
-
(2003)
J Healthc Inf Manag
, vol.17
, pp. 37-41
-
-
Harris, C.M.1
Burns, J.2
Gregorich, T.3
Kall, G.4
Piar, P.M.5
Miller, H.D.6
-
19
-
-
0032247256
-
Physician use of an ambulatory medical record system: Matching form and function
-
Folz-Murphy N, Partin M, Williams L, Harris CM, Lauer MS. Physician use of an ambulatory medical record system: matching form and function. Proc AMIA Symp. 1998:260-4.
-
(1998)
Proc AMIA Symp
, pp. 260-264
-
-
Folz-Murphy, N.1
Partin, M.2
Williams, L.3
Harris, C.M.4
Lauer, M.S.5
-
21
-
-
0043192680
-
Online records serve patients, clinicians, and HIM
-
quiz 39-40
-
Foster E, Miller H, Partin M, Lockshaw J, Fogelman A, Folz-Murphy N, et al. Online records serve patients, clinicians, and HIM. J AHIMA. 2003;74:34-7; quiz 39-40.
-
(2003)
J AHIMA
, vol.74
, pp. 34-37
-
-
Foster, E.1
Miller, H.2
Partin, M.3
Lockshaw, J.4
Fogelman, A.5
Folz-Murphy, N.6
-
22
-
-
0034707105
-
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
-
VIGOR Study Group. 2 p following 1528
-
Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med. 2000;343:1520-8, 2 p following 1528.
-
(2000)
N Engl J Med
, vol.343
, pp. 1520-1528
-
-
Bombardier, C.1
Laine, L.2
Reicin, A.3
Shapiro, D.4
Burgos-Vargas, R.5
Davis, B.6
-
23
-
-
85007729496
-
Is the FDA approving drugs too fast? Probably not - But drug recalls have sparked debate
-
Kleinke JD, Gottlieb S. Is the FDA approving drugs too fast? Probably not - but drug recalls have sparked debate [Editorial]. BMJ. 1998;317:899.
-
(1998)
BMJ
, vol.317
, pp. 899
-
-
Kleinke, J.D.1
Gottlieb, S.2
-
24
-
-
0033549140
-
The safety of new medicines: The importance of asking the right questions
-
Wood AJ. The safety of new medicines: the importance of asking the right questions [Editorial]. JAMA. 1999;281:1753-4.
-
(1999)
JAMA
, vol.281
, pp. 1753-1754
-
-
Wood, A.J.1
-
25
-
-
0033549087
-
The safety of newly approved medicines: Do recent market removals mean there is a problem?
-
Friedman MA, Woodcock J, Lumpkin MM, Shuren JE, Hass AE, Thompson LJ. The safety of newly approved medicines: do recent market removals mean there is a problem? JAMA. 1999;281:1728-34.
-
(1999)
JAMA
, vol.281
, pp. 1728-1734
-
-
Friedman, M.A.1
Woodcock, J.2
Lumpkin, M.M.3
Shuren, J.E.4
Hass, A.E.5
Thompson, L.J.6
-
26
-
-
0032556180
-
Effect of computerized physician order entry and a team intervention on prevention of serious medication errors
-
Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998;280:1311-6.
-
(1998)
JAMA
, vol.280
, pp. 1311-1316
-
-
Bates, D.W.1
Leape, L.L.2
Cullen, D.J.3
Laird, N.4
Petersen, L.A.5
Teich, J.M.6
-
27
-
-
0037663736
-
Effects of computerized physician order entry and clinical decision support systems on medication safety: A systematic review
-
Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med. 2003;163:1409-16.
-
(2003)
Arch Intern Med
, vol.163
, pp. 1409-1416
-
-
Kaushal, R.1
Shojania, K.G.2
Bates, D.W.3
-
29
-
-
3242758259
-
Users of Internet health information: Differences by health status
-
Houston TK, Allison JJ. Users of Internet health information: differences by health status. J Med Internet Res. 2002;4:E7.
-
(2002)
J Med Internet Res
, vol.4
-
-
Houston, T.K.1
Allison, J.J.2
-
30
-
-
0344341695
-
The incidence of limb and ear defects since the withdrawal of thalidomide
-
Smithells RW. The incidence of limb and ear defects since the withdrawal of thalidomide. Lancet. 1963:1:1095-7.
-
(1963)
Lancet
, vol.1
, pp. 1095-1097
-
-
Smithells, R.W.1
|